{"title":"[Risk factors of thromboembolism associated with pregnancy and the puerperium. Role of inherited and acquired thrombophilia].","authors":"Anne-Sophie Ducloy-Bouthors, Nathalie Trillot","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Thromboembolism in pregnancy and the puerperium and inherited or acquired thrombophilia are associated. Thrombophilia can be revealed by pregnancy. Thrombotic risk during pregnancy and the puerperium is higher in asymptomatic women with than without thrombophilia. Antithrombin deficiency, combined deficiencies and homozygous or double-heterozygotes factor V Leiden and factor II G 20210 A mutations are associated with a higher thrombotic risk than heterozygote mutations or protein S and C deficiencies, whereas hyperhomocysteinemia does not appear as a risk factor for maternal thromboembolic disease. Antiphospholipid syndrome with lupus anticoagulant is strongly associated with thrombotic risk in pregnancy and the puerperium. Further studies are required to assess the thrombotic risk in women with preeclampsia as well as early or late recurrent pregnancy loss.</p>","PeriodicalId":75505,"journal":{"name":"Annales de medecine interne","volume":" ","pages":"295-300"},"PeriodicalIF":0.0000,"publicationDate":"2003-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annales de medecine interne","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Thromboembolism in pregnancy and the puerperium and inherited or acquired thrombophilia are associated. Thrombophilia can be revealed by pregnancy. Thrombotic risk during pregnancy and the puerperium is higher in asymptomatic women with than without thrombophilia. Antithrombin deficiency, combined deficiencies and homozygous or double-heterozygotes factor V Leiden and factor II G 20210 A mutations are associated with a higher thrombotic risk than heterozygote mutations or protein S and C deficiencies, whereas hyperhomocysteinemia does not appear as a risk factor for maternal thromboembolic disease. Antiphospholipid syndrome with lupus anticoagulant is strongly associated with thrombotic risk in pregnancy and the puerperium. Further studies are required to assess the thrombotic risk in women with preeclampsia as well as early or late recurrent pregnancy loss.
妊娠期和产褥期血栓栓塞与遗传性或获得性血栓病相关。血栓症可通过妊娠表现出来。妊娠和产褥期血栓形成的风险在无症状的有血栓形成的妇女中高于无血栓形成的妇女。抗凝血酶缺乏症、联合缺乏症、纯合子或双杂合子因子V Leiden和因子II G 20210a突变比杂合子突变或蛋白S和C缺乏症与更高的血栓形成风险相关,而高同型半胱氨酸血症并不是母体血栓栓塞性疾病的危险因素。抗磷脂综合征狼疮抗凝剂与妊娠和产褥期血栓形成风险密切相关。需要进一步的研究来评估先兆子痫妇女以及早期或晚期复发性妊娠丢失的血栓形成风险。